An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms

Rachel J Moreno1,2, Paul Ashwood1,2

  • 1Department of Medical Microbiology and Immunology, University of California, Davis, CA 95616, USA.

Insights

Microbial dysbiosis in the gut is common in autism spectrum disorder (ASD). Manipulating the gut microbiome through various methods shows promise for improving ASD behaviors and gastrointestinal issues.

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology

Background:

  • Autism spectrum disorder (ASD) affects 1 in 33 children in the US, characterized by social interaction and communication challenges.
  • Microbial dysbiosis in the gastrointestinal tract is frequently observed in individuals with ASD, potentially worsening symptoms and immune dysregulation.
  • GI comorbidities are more prevalent in the ASD population, possibly linked to dysbiosis and immune issues.

Purpose of the Study:

  • To review the impact of microbial manipulation on autism spectrum disorder (ASD) outcomes.
  • To discuss various methods of microbiome manipulation and their efficacy in ASD.
  • To explore the potential of early-life microbiome interventions for neurodevelopment.

Main Methods:

  • Review of preclinical and clinical studies on microbiome manipulation in ASD.
  • Analysis of interventions including antibiotics, dietary changes, prebiotics, probiotics, and fecal microbiota transplantation.
  • Discussion of research on early-life microbiome interventions.

Main Results:

  • Various microbiome manipulation methods have demonstrated varying success in reducing ASD behaviors and GI symptoms.
  • Long-term efficacy of these interventions varies.
  • Early-life intervention is a critical period for neurodevelopment and microbiome manipulation.

Conclusions:

  • Microbiome manipulation is a promising area of research for managing ASD symptoms and associated GI issues.
  • Further research is needed to optimize interventions and understand long-term effects.
  • Targeting the microbiome early in life may offer significant benefits for neurodevelopment in ASD.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
59
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
166
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
107
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
244
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.5K